Result of AGM, Board, Fundraising and Sub-division
R8 Capital Investments PLC
21 August 2026
21 August 2026
R8 CAPITAL INVESTMENTS PLC
("R8", or the "Company")
RESULT OF ANNUAL GENERAL MEETING
BOARD CHANGES
£500,000 FUNDRAISING UPDATE
COMPLETION OF SUB-DIVISION
Annual General Meeting Result
R8 Capital Investments PLC, is pleased to announce that all of the Resolutions put before the Company's Annual General Meeting ("AGM") held today, 21 August 2026, at 10:00am were duly passed.
Fundraising Update
The Company is also pleased to confirm that, subject to receipt of funds, all other conditions to the £500,000 Fundraising via AlbR Capital, combining a Placing and a Subscription for a mixture of New Ordinary Shares and CLNs, have now been satisfied. Admission to trading of the Fundraising Shares is expected to occur as stipulated in the timetable set out in the Company's announcement of 20 August 2026.
The Company will provide a further update once the Fundraise has completed.
Board Changes
Following the passing of all the Resolutions at the AGM and subject to completion of the Fundraising, David Mason and Neil Jeffrey will be joining the Board as Non-Executive Directors and Jonathan Rowland and Richard Morecroft will resign from the Board.
Further information on David Mason
Directorships and further disclosures in relation to David Mason are as follows:
Current directorships / partnerships:
- Sovereign International Limited
- Lamera Capital Limited
Previous directorships / partnerships held within the last five years:
- Aspire Payments Limited
- Finseta Payment Solutions Limited
Save as set out above, there is no further information to be disclosed in respect of David Mason pursuant to UKLR 6.4.8R.
Further information on Neil Jeffrey
Current directorships / partnerships:
- GCN Finance Limited
Previous directorships / partnerships held within the last five years:
- Payment Assist (UK) Ltd
Save as set out above, there is no further information to be disclosed in respect of Neil Jeffrey pursuant to UKLR 6.4.8R.
Sub-division and Total Voting Rights
Following the passing of the Resolutions, and as a result of the Sub-division, there will be 107,411,062 Ordinary Shares of £0.0001 in issue and it is expected that admission to trading of the sub-divided Ordinary Shares will take place on 26 August 2026.
In accordance with DTR 5.6.1R of the FCA's Disclosure Guidance and Transparency Rules, R8 announces that, the Company's issued share capital will consist of:
107,411,062 ordinary shares of £0.0001 each, each carrying one voting right.
The Company does not hold any ordinary shares in treasury.
Accordingly, the total number of voting rights in the Company as at the date of this announcement is 107,411,062.
The above figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
Capitalised terms in this announcement shall have the same meaning as given in the Company's shareholder circular and notice of AGM dated 15 July 2026 and the Company's announcement of 20 August 2026.
The Directors of the Company accept responsibility for the contents of this announcement.
- ENDS -
Enquiries:
|
Company Jonathan Rowland / Richard Morecroft |
info@r8plc.com |
|
Peterhouse Capital Limited Corporate Broker Duncan Vasey |
+ 44 (0) 20 7469 0930 |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.